Relay Therapeutics CFO sells 17,717 shares in Form 4 filing
Relay Therapeutics Chief Financial Officer Thomas Catinazzo reported selling 17,717 shares at $18.59 each in a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Relay Therapeutics Chief Financial Officer Thomas Catinazzo reported selling 17,717 shares at $18.59 each in a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.
Relay Therapeutics CEO Sanjiv Patel sold 48,199 shares at $18.10 each, according to a Form 4 filing. The filing says the sale was made under a 10b5-1 plan.